Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Rectal Cancer
Interventions
DRUG

Capecitabine

chemotherapy oral use

DRUG

Oxaliplatin

chemotherapy intravenous use

Trial Locations (8)

1090

Medical University of Vienna, Radiotherapy, Vienna

2700

Hospital Wiener Neustadt, Wiener Neustadt

4600

Klinikum Wels-Grieskirchen GmbH, Wels

5020

Paracelsus Medical University Salzburg - Oncology, Salzburg

6020

Medical University of Innsbruck, Surgery, Innsbruck

8036

Medical University of Graz, Oncology, Graz

8700

State Hospital Leoben, Surgery, Leoben

9330

Hospital BHB St. Veit/Glan, Surgery, Saint Veit A. D. Glan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi-Synthelabo

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

Austrian Breast & Colorectal Cancer Study Group

NETWORK